It was then that Actavis, a drug company that specializes in generic drugs and over-the-counter products, scooped up Allergan for a neat $66 billion. Here's a photo of Actavis CEO Brenton Saunders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback